Global Precision Medicine Market Analysis and Forecast 2024-2030
According to the National Institutes of Health (NIH), precision medicine is 'an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.' This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a 'one-size-fits-all' approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term 'precision medicine' is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
According to APO Research, The global Precision Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
Report Includes
This report presents an overview of global market for Precision Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Precision Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Precision Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Precision Medicine revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Precision Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Precision Medicine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation and Biomrieux Sa, etc.
Precision Medicine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Precision Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Precision Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Medicine revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Chapter 13: The main concluding insights of the report.
Although the term 'precision medicine' is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
According to APO Research, The global Precision Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
Report Includes
This report presents an overview of global market for Precision Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Precision Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Precision Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Precision Medicine revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Precision Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Precision Medicine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, Illumina, GE Healthcare, Intel Corporation and Biomrieux Sa, etc.
Precision Medicine segment by Company
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux Sa
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
- Diagnostics
- Therapies
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Precision Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Precision Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Precision Medicine revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Precision Medicine Market by Type
1.2.1 Global Precision Medicine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Precision Medicine Market by Application
1.3.1 Global Precision Medicine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRECISION MEDICINE MARKET DYNAMICS
2.1 Precision Medicine Industry Trends
2.2 Precision Medicine Industry Drivers
2.3 Precision Medicine Industry Opportunities and Challenges
2.4 Precision Medicine Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Precision Medicine Market Perspective (2019-2030)
3.2 Global Precision Medicine Growth Trends by Region
3.2.1 Global Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Precision Medicine Market Size by Region (2019-2024)
3.2.3 Global Precision Medicine Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Precision Medicine Revenue by Players
4.1.1 Global Precision Medicine Revenue by Players (2019-2024)
4.1.2 Global Precision Medicine Revenue Market Share by Players (2019-2024)
4.1.3 Global Precision Medicine Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Precision Medicine Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Precision Medicine Key Players Headquarters & Area Served
4.4 Global Precision Medicine Players, Product Type & Application
4.5 Global Precision Medicine Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Precision Medicine Market CR5 and HHI
4.6.2 Global Top 5 and 10 Precision Medicine Players Market Share by Revenue in 2023
4.6.3 2023 Precision Medicine Tier 1, Tier 2, and Tier
5 PRECISION MEDICINE MARKET SIZE BY TYPE
5.1 Global Precision Medicine Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Precision Medicine Revenue by Type (2019-2030)
5.3 Global Precision Medicine Revenue Market Share by Type (2019-2030)
6 PRECISION MEDICINE MARKET SIZE BY APPLICATION
6.1 Global Precision Medicine Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Precision Medicine Revenue by Application (2019-2030)
6.3 Global Precision Medicine Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Comapny Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Precision Medicine Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Precision Medicine Product Portfolio
7.1.5 Johnson & Johnson Recent Developments
7.2 Roche
7.2.1 Roche Comapny Information
7.2.2 Roche Business Overview
7.2.3 Roche Precision Medicine Revenue and Gross Margin (2019-2024)
7.2.4 Roche Precision Medicine Product Portfolio
7.2.5 Roche Recent Developments
7.3 Labcorp
7.3.1 Labcorp Comapny Information
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Precision Medicine Revenue and Gross Margin (2019-2024)
7.3.4 Labcorp Precision Medicine Product Portfolio
7.3.5 Labcorp Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Comapny Information
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Precision Medicine Revenue and Gross Margin (2019-2024)
7.4.4 Abbott Laboratories Precision Medicine Product Portfolio
7.4.5 Abbott Laboratories Recent Developments
7.5 Novartis
7.5.1 Novartis Comapny Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Precision Medicine Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Precision Medicine Product Portfolio
7.5.5 Novartis Recent Developments
7.6 Illumina
7.6.1 Illumina Comapny Information
7.6.2 Illumina Business Overview
7.6.3 Illumina Precision Medicine Revenue and Gross Margin (2019-2024)
7.6.4 Illumina Precision Medicine Product Portfolio
7.6.5 Illumina Recent Developments
7.7 GE Healthcare
7.7.1 GE Healthcare Comapny Information
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Precision Medicine Revenue and Gross Margin (2019-2024)
7.7.4 GE Healthcare Precision Medicine Product Portfolio
7.7.5 GE Healthcare Recent Developments
7.8 Intel Corporation
7.8.1 Intel Corporation Comapny Information
7.8.2 Intel Corporation Business Overview
7.8.3 Intel Corporation Precision Medicine Revenue and Gross Margin (2019-2024)
7.8.4 Intel Corporation Precision Medicine Product Portfolio
7.8.5 Intel Corporation Recent Developments
7.9 Biomrieux Sa
7.9.1 Biomrieux Sa Comapny Information
7.9.2 Biomrieux Sa Business Overview
7.9.3 Biomrieux Sa Precision Medicine Revenue and Gross Margin (2019-2024)
7.9.4 Biomrieux Sa Precision Medicine Product Portfolio
7.9.5 Biomrieux Sa Recent Developments
7.10 Cepheid
7.10.1 Cepheid Comapny Information
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Precision Medicine Revenue and Gross Margin (2019-2024)
7.10.4 Cepheid Precision Medicine Product Portfolio
7.10.5 Cepheid Recent Developments
7.11 IBM
7.11.1 IBM Comapny Information
7.11.2 IBM Business Overview
7.11.3 IBM Precision Medicine Revenue and Gross Margin (2019-2024)
7.11.4 IBM Precision Medicine Product Portfolio
7.11.5 IBM Recent Developments
7.12 Qiagen
7.12.1 Qiagen Comapny Information
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Precision Medicine Revenue and Gross Margin (2019-2024)
7.12.4 Qiagen Precision Medicine Product Portfolio
7.12.5 Qiagen Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Comapny Information
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Precision Medicine Revenue and Gross Margin (2019-2024)
7.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Randox Laboratories
7.14.1 Randox Laboratories Comapny Information
7.14.2 Randox Laboratories Business Overview
7.14.3 Randox Laboratories Precision Medicine Revenue and Gross Margin (2019-2024)
7.14.4 Randox Laboratories Precision Medicine Product Portfolio
7.14.5 Randox Laboratories Recent Developments
7.15 Almac Group
7.15.1 Almac Group Comapny Information
7.15.2 Almac Group Business Overview
7.15.3 Almac Group Precision Medicine Revenue and Gross Margin (2019-2024)
7.15.4 Almac Group Precision Medicine Product Portfolio
7.15.5 Almac Group Recent Developments
7.16 Healthcore
7.16.1 Healthcore Comapny Information
7.16.2 Healthcore Business Overview
7.16.3 Healthcore Precision Medicine Revenue and Gross Margin (2019-2024)
7.16.4 Healthcore Precision Medicine Product Portfolio
7.16.5 Healthcore Recent Developments
8 NORTH AMERICA
8.1 North America Precision Medicine Revenue (2019-2030)
8.2 North America Precision Medicine Revenue by Type (2019-2030)
8.2.1 North America Precision Medicine Revenue by Type (2019-2024)
8.2.2 North America Precision Medicine Revenue by Type (2025-2030)
8.3 North America Precision Medicine Revenue Share by Type (2019-2030)
8.4 North America Precision Medicine Revenue by Application (2019-2030)
8.4.1 North America Precision Medicine Revenue by Application (2019-2024)
8.4.2 North America Precision Medicine Revenue by Application (2025-2030)
8.5 North America Precision Medicine Revenue Share by Application (2019-2030)
8.6 North America Precision Medicine Revenue by Country
8.6.1 North America Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Precision Medicine Revenue by Country (2019-2024)
8.6.3 North America Precision Medicine Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Precision Medicine Revenue (2019-2030)
9.2 Europe Precision Medicine Revenue by Type (2019-2030)
9.2.1 Europe Precision Medicine Revenue by Type (2019-2024)
9.2.2 Europe Precision Medicine Revenue by Type (2025-2030)
9.3 Europe Precision Medicine Revenue Share by Type (2019-2030)
9.4 Europe Precision Medicine Revenue by Application (2019-2030)
9.4.1 Europe Precision Medicine Revenue by Application (2019-2024)
9.4.2 Europe Precision Medicine Revenue by Application (2025-2030)
9.5 Europe Precision Medicine Revenue Share by Application (2019-2030)
9.6 Europe Precision Medicine Revenue by Country
9.6.1 Europe Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Precision Medicine Revenue by Country (2019-2024)
9.6.3 Europe Precision Medicine Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Precision Medicine Revenue (2019-2030)
10.2 China Precision Medicine Revenue by Type (2019-2030)
10.2.1 China Precision Medicine Revenue by Type (2019-2024)
10.2.2 China Precision Medicine Revenue by Type (2025-2030)
10.3 China Precision Medicine Revenue Share by Type (2019-2030)
10.4 China Precision Medicine Revenue by Application (2019-2030)
10.4.1 China Precision Medicine Revenue by Application (2019-2024)
10.4.2 China Precision Medicine Revenue by Application (2025-2030)
10.5 China Precision Medicine Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Precision Medicine Revenue (2019-2030)
11.2 Asia Precision Medicine Revenue by Type (2019-2030)
11.2.1 Asia Precision Medicine Revenue by Type (2019-2024)
11.2.2 Asia Precision Medicine Revenue by Type (2025-2030)
11.3 Asia Precision Medicine Revenue Share by Type (2019-2030)
11.4 Asia Precision Medicine Revenue by Application (2019-2030)
11.4.1 Asia Precision Medicine Revenue by Application (2019-2024)
11.4.2 Asia Precision Medicine Revenue by Application (2025-2030)
11.5 Asia Precision Medicine Revenue Share by Application (2019-2030)
11.6 Asia Precision Medicine Revenue by Country
11.6.1 Asia Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Precision Medicine Revenue by Country (2019-2024)
11.6.3 Asia Precision Medicine Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Precision Medicine Revenue (2019-2030)
12.2 MEALA Precision Medicine Revenue by Type (2019-2030)
12.2.1 MEALA Precision Medicine Revenue by Type (2019-2024)
12.2.2 MEALA Precision Medicine Revenue by Type (2025-2030)
12.3 MEALA Precision Medicine Revenue Share by Type (2019-2030)
12.4 MEALA Precision Medicine Revenue by Application (2019-2030)
12.4.1 MEALA Precision Medicine Revenue by Application (2019-2024)
12.4.2 MEALA Precision Medicine Revenue by Application (2025-2030)
12.5 MEALA Precision Medicine Revenue Share by Application (2019-2030)
12.6 MEALA Precision Medicine Revenue by Country
12.6.1 MEALA Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Precision Medicine Revenue by Country (2019-2024)
12.6.3 MEALA Precision Medicine Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Precision Medicine Market by Type
1.2.1 Global Precision Medicine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Diagnostics
1.2.3 Therapies
1.3 Precision Medicine Market by Application
1.3.1 Global Precision Medicine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRECISION MEDICINE MARKET DYNAMICS
2.1 Precision Medicine Industry Trends
2.2 Precision Medicine Industry Drivers
2.3 Precision Medicine Industry Opportunities and Challenges
2.4 Precision Medicine Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Precision Medicine Market Perspective (2019-2030)
3.2 Global Precision Medicine Growth Trends by Region
3.2.1 Global Precision Medicine Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Precision Medicine Market Size by Region (2019-2024)
3.2.3 Global Precision Medicine Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Precision Medicine Revenue by Players
4.1.1 Global Precision Medicine Revenue by Players (2019-2024)
4.1.2 Global Precision Medicine Revenue Market Share by Players (2019-2024)
4.1.3 Global Precision Medicine Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Precision Medicine Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Precision Medicine Key Players Headquarters & Area Served
4.4 Global Precision Medicine Players, Product Type & Application
4.5 Global Precision Medicine Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Precision Medicine Market CR5 and HHI
4.6.2 Global Top 5 and 10 Precision Medicine Players Market Share by Revenue in 2023
4.6.3 2023 Precision Medicine Tier 1, Tier 2, and Tier
5 PRECISION MEDICINE MARKET SIZE BY TYPE
5.1 Global Precision Medicine Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Precision Medicine Revenue by Type (2019-2030)
5.3 Global Precision Medicine Revenue Market Share by Type (2019-2030)
6 PRECISION MEDICINE MARKET SIZE BY APPLICATION
6.1 Global Precision Medicine Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Precision Medicine Revenue by Application (2019-2030)
6.3 Global Precision Medicine Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Comapny Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Precision Medicine Revenue and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Precision Medicine Product Portfolio
7.1.5 Johnson & Johnson Recent Developments
7.2 Roche
7.2.1 Roche Comapny Information
7.2.2 Roche Business Overview
7.2.3 Roche Precision Medicine Revenue and Gross Margin (2019-2024)
7.2.4 Roche Precision Medicine Product Portfolio
7.2.5 Roche Recent Developments
7.3 Labcorp
7.3.1 Labcorp Comapny Information
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Precision Medicine Revenue and Gross Margin (2019-2024)
7.3.4 Labcorp Precision Medicine Product Portfolio
7.3.5 Labcorp Recent Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Comapny Information
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Precision Medicine Revenue and Gross Margin (2019-2024)
7.4.4 Abbott Laboratories Precision Medicine Product Portfolio
7.4.5 Abbott Laboratories Recent Developments
7.5 Novartis
7.5.1 Novartis Comapny Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Precision Medicine Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Precision Medicine Product Portfolio
7.5.5 Novartis Recent Developments
7.6 Illumina
7.6.1 Illumina Comapny Information
7.6.2 Illumina Business Overview
7.6.3 Illumina Precision Medicine Revenue and Gross Margin (2019-2024)
7.6.4 Illumina Precision Medicine Product Portfolio
7.6.5 Illumina Recent Developments
7.7 GE Healthcare
7.7.1 GE Healthcare Comapny Information
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Precision Medicine Revenue and Gross Margin (2019-2024)
7.7.4 GE Healthcare Precision Medicine Product Portfolio
7.7.5 GE Healthcare Recent Developments
7.8 Intel Corporation
7.8.1 Intel Corporation Comapny Information
7.8.2 Intel Corporation Business Overview
7.8.3 Intel Corporation Precision Medicine Revenue and Gross Margin (2019-2024)
7.8.4 Intel Corporation Precision Medicine Product Portfolio
7.8.5 Intel Corporation Recent Developments
7.9 Biomrieux Sa
7.9.1 Biomrieux Sa Comapny Information
7.9.2 Biomrieux Sa Business Overview
7.9.3 Biomrieux Sa Precision Medicine Revenue and Gross Margin (2019-2024)
7.9.4 Biomrieux Sa Precision Medicine Product Portfolio
7.9.5 Biomrieux Sa Recent Developments
7.10 Cepheid
7.10.1 Cepheid Comapny Information
7.10.2 Cepheid Business Overview
7.10.3 Cepheid Precision Medicine Revenue and Gross Margin (2019-2024)
7.10.4 Cepheid Precision Medicine Product Portfolio
7.10.5 Cepheid Recent Developments
7.11 IBM
7.11.1 IBM Comapny Information
7.11.2 IBM Business Overview
7.11.3 IBM Precision Medicine Revenue and Gross Margin (2019-2024)
7.11.4 IBM Precision Medicine Product Portfolio
7.11.5 IBM Recent Developments
7.12 Qiagen
7.12.1 Qiagen Comapny Information
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Precision Medicine Revenue and Gross Margin (2019-2024)
7.12.4 Qiagen Precision Medicine Product Portfolio
7.12.5 Qiagen Recent Developments
7.13 Thermo Fisher Scientific
7.13.1 Thermo Fisher Scientific Comapny Information
7.13.2 Thermo Fisher Scientific Business Overview
7.13.3 Thermo Fisher Scientific Precision Medicine Revenue and Gross Margin (2019-2024)
7.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
7.13.5 Thermo Fisher Scientific Recent Developments
7.14 Randox Laboratories
7.14.1 Randox Laboratories Comapny Information
7.14.2 Randox Laboratories Business Overview
7.14.3 Randox Laboratories Precision Medicine Revenue and Gross Margin (2019-2024)
7.14.4 Randox Laboratories Precision Medicine Product Portfolio
7.14.5 Randox Laboratories Recent Developments
7.15 Almac Group
7.15.1 Almac Group Comapny Information
7.15.2 Almac Group Business Overview
7.15.3 Almac Group Precision Medicine Revenue and Gross Margin (2019-2024)
7.15.4 Almac Group Precision Medicine Product Portfolio
7.15.5 Almac Group Recent Developments
7.16 Healthcore
7.16.1 Healthcore Comapny Information
7.16.2 Healthcore Business Overview
7.16.3 Healthcore Precision Medicine Revenue and Gross Margin (2019-2024)
7.16.4 Healthcore Precision Medicine Product Portfolio
7.16.5 Healthcore Recent Developments
8 NORTH AMERICA
8.1 North America Precision Medicine Revenue (2019-2030)
8.2 North America Precision Medicine Revenue by Type (2019-2030)
8.2.1 North America Precision Medicine Revenue by Type (2019-2024)
8.2.2 North America Precision Medicine Revenue by Type (2025-2030)
8.3 North America Precision Medicine Revenue Share by Type (2019-2030)
8.4 North America Precision Medicine Revenue by Application (2019-2030)
8.4.1 North America Precision Medicine Revenue by Application (2019-2024)
8.4.2 North America Precision Medicine Revenue by Application (2025-2030)
8.5 North America Precision Medicine Revenue Share by Application (2019-2030)
8.6 North America Precision Medicine Revenue by Country
8.6.1 North America Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Precision Medicine Revenue by Country (2019-2024)
8.6.3 North America Precision Medicine Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Precision Medicine Revenue (2019-2030)
9.2 Europe Precision Medicine Revenue by Type (2019-2030)
9.2.1 Europe Precision Medicine Revenue by Type (2019-2024)
9.2.2 Europe Precision Medicine Revenue by Type (2025-2030)
9.3 Europe Precision Medicine Revenue Share by Type (2019-2030)
9.4 Europe Precision Medicine Revenue by Application (2019-2030)
9.4.1 Europe Precision Medicine Revenue by Application (2019-2024)
9.4.2 Europe Precision Medicine Revenue by Application (2025-2030)
9.5 Europe Precision Medicine Revenue Share by Application (2019-2030)
9.6 Europe Precision Medicine Revenue by Country
9.6.1 Europe Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Precision Medicine Revenue by Country (2019-2024)
9.6.3 Europe Precision Medicine Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Precision Medicine Revenue (2019-2030)
10.2 China Precision Medicine Revenue by Type (2019-2030)
10.2.1 China Precision Medicine Revenue by Type (2019-2024)
10.2.2 China Precision Medicine Revenue by Type (2025-2030)
10.3 China Precision Medicine Revenue Share by Type (2019-2030)
10.4 China Precision Medicine Revenue by Application (2019-2030)
10.4.1 China Precision Medicine Revenue by Application (2019-2024)
10.4.2 China Precision Medicine Revenue by Application (2025-2030)
10.5 China Precision Medicine Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Precision Medicine Revenue (2019-2030)
11.2 Asia Precision Medicine Revenue by Type (2019-2030)
11.2.1 Asia Precision Medicine Revenue by Type (2019-2024)
11.2.2 Asia Precision Medicine Revenue by Type (2025-2030)
11.3 Asia Precision Medicine Revenue Share by Type (2019-2030)
11.4 Asia Precision Medicine Revenue by Application (2019-2030)
11.4.1 Asia Precision Medicine Revenue by Application (2019-2024)
11.4.2 Asia Precision Medicine Revenue by Application (2025-2030)
11.5 Asia Precision Medicine Revenue Share by Application (2019-2030)
11.6 Asia Precision Medicine Revenue by Country
11.6.1 Asia Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Precision Medicine Revenue by Country (2019-2024)
11.6.3 Asia Precision Medicine Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Precision Medicine Revenue (2019-2030)
12.2 MEALA Precision Medicine Revenue by Type (2019-2030)
12.2.1 MEALA Precision Medicine Revenue by Type (2019-2024)
12.2.2 MEALA Precision Medicine Revenue by Type (2025-2030)
12.3 MEALA Precision Medicine Revenue Share by Type (2019-2030)
12.4 MEALA Precision Medicine Revenue by Application (2019-2030)
12.4.1 MEALA Precision Medicine Revenue by Application (2019-2024)
12.4.2 MEALA Precision Medicine Revenue by Application (2025-2030)
12.5 MEALA Precision Medicine Revenue Share by Application (2019-2030)
12.6 MEALA Precision Medicine Revenue by Country
12.6.1 MEALA Precision Medicine Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Precision Medicine Revenue by Country (2019-2024)
12.6.3 MEALA Precision Medicine Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
